SEC Tracker
Get the app

Cavitation Technologies CVAT

Cavitation Technologies Q3 FY24: revenue $519K; diluted EPS $0.00

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Cavitation Technologies reported for Q3 FY24, the quarter ended Mar 31, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$519KNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Net income$331KNo year-earlier figure tagged10-Q income statement, on EDGAR
  3. Diluted EPS$0.00No year-earlier figure tagged10-Q income statement, on EDGAR
  4. Cash and cash equivalents$183KNo year-earlier figure tagged10-Q balance sheet, on EDGAR
  5. Cash from operations$176KNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Cavitation Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 700 and related industry codes: the same peer list as the financial tables.

  1. RYTHM RYM public float $27M, Jun 30, 2025
  2. Chase Packaging WHLT public float $4M, Jun 30, 2025
  3. BNB Standard BNC public float $324M, Oct 31, 2025
  4. Mission Produce AVO public float $496M, Apr 30, 2025, over 18 months old
  5. Calavo Growers CVGW public float $500M, Apr 30, 2025, over 18 months old